This live satellite symposium describes the variety of antiarrhythmic drugs that are available and presents the rationale for using them to manage atrial fibrillation. This clinician-oriented program focuses on both inpatient and outpatient care. Issues such as which drug class to use, the adverse effects (QT prolongation), drug-drug interactions, organ toxicity, tradeoffs, cost, effect on length of hospital stay, and how and when to use IV antiarrhythmic drugs will be highlighted.
This program is not part of the 2022 Heart Rhythm Scientific Sessions as planned by the Scientific Sessions Program Committee.
This event is neither sponsored nor endorsed by the Heart Rhythm Society.